Ashwin Somasundaram Archives

The rise of colorectal cancer cases in people under 45 has steadily increased, prompting concern among oncologists and researchers. Ashwin Somasundaram, MD, talks about colorectal cancer and this concerning trend.

Human colon cancer cells with the cell nuclei stained red and the protein E-cadherin stained green. E-cadherin is a cell adhesion molecule and its loss signals a process known as the epithelial-mesenchymal transition in which cells acquire the ability to migrate and become invasive.

UNC Lineberger researchers have demonstrated that combining two immunotherapy drugs with a targeted therapy drug proved effective in treating the most common form of metastatic colorectal cancer.

UNC Lineberger has opened a two-arm clinical trial to determine the optimal combination treatment for patients with advanced unresectable or metastatic basal-like subtype pancreatic ductal adenocarcinoma.

Naim Rashid, PhD, has received a Department of Defense Pancreatic Cancer Research Program pilot award to build an AI tool that generates personalized clinical trial recommendations for patients with PDAC.

Seven arms in a circle with a diverse range of skin tones.

The PROmoting CLinicAl TrIal EngageMent for Pancreatic Cancer App Study (PROCLAIM Study), which is focused on breaking down barriers to diverse clinical trial population recruitment, is enrolling patients.

UNC Lineberger's annual scientific retreat brought together faculty, staff and trainees to learn about the latest research at the cancer center.

The National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.

We’re proud to announce Ashwin Somasundaram, MD, as the newest member of the UNC Lineberger Pancreatic Cancer Center of Excellence (PCCE).

“In my opinion, there seems to be no greater puzzle worth solving for my generation than the treatment of cancer,” says Dr. Somasundaram, who recently joined the PCCE.

Tag: Ashwin Somasundaram

Gastrointestinal oncologist discusses increase in younger patients with colorectal cancer

Immunotherapy and targeted therapy combination proves effective against metastatic colorectal cancer

Study now recruiting patients to treat PANcreatic adenocarcinoma with Gemcitabine, Erlotinib, and nAb-paclitaxel (PANGEA)

Rashid awarded grant to develop AI tool that recommends optimal clinical trials to pancreatic cancer patients

WRAL: Survivor shares cancer journey after Kate Middleton’s message

PROCLAIM Study open to accrual

Scientific retreat underscores impact and promise of cancer center’s research

UNC Lineberger pancreatic cancer therapy studies backed by 5-year, $10.9 million NIH SPORE grant

Welcoming Ashwin Somasundaram

A Conversation with Dr. Somasundaram